Imaging criteria across pivotal randomized controlled trials for late window thrombectomy patient selection
暂无分享,去创建一个
Thalia Shoshana Field | A. Demchuk | R. Nogueira | R. McTaggart | M. Hill | M. Tymianski | B. van Adel | B. Menon | M. Goyal | J. Rempel | D. Heck | M. Psychogios | M. Almekhlafi | D. Dowlatshahi | A. Poppe | O. Bang | E. Sauvageau | C. Zerna | T. Moreira | J. Tarpley | J. Ospel | M. Joshi
[1] G. Albers,et al. Prediction of death after endovascular thrombectomy in the extended window: a secondary analysis of DEFUSE 3 " , 2020, Journal of NeuroInterventional Surgery.
[2] W. Hacke,et al. Challenging the Ischemic Core Concept in Acute Ischemic Stroke Imaging , 2020, Stroke.
[3] M. Mlynash,et al. What predicts poor outcome after successful thrombectomy in late time windows? , 2020, Journal of NeuroInterventional Surgery.
[4] A. Demchuk,et al. Discrepancy between post-treatment infarct volume and 90-day outcome in the ESCAPE randomized controlled trial , 2020, International journal of stroke : official journal of the International Stroke Society.
[5] Thalia Shoshana Field,et al. Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial. , 2020, The Lancet.
[6] A. Demchuk,et al. Imaging Triage of Patients with Late-Window (6–24 Hours) Acute Ischemic Stroke: A Comparative Study Using Multiphase CT Angiography versus CT Perfusion , 2019, American Journal of Neuroradiology.
[7] Brenda J Butka. Imaging , 2003, JAMA.
[9] M. Wintermark,et al. Eligibility for late endovascular treatment using DAWN, DEFUSE-3, and more liberal selection criteria in a stroke center , 2019, Journal of NeuroInterventional Surgery.
[10] W. Powers,et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. , 2019, Stroke.
[11] Wade S. Smith,et al. Outcome in Direct Versus Transfer Patients in the DAWN Controlled Trial. , 2019, Stroke.
[12] M. Mlynash,et al. Outcomes of Thrombectomy in Transferred Patients With Ischemic Stroke in the Late Window: A Subanalysis From the DEFUSE 3 Trial. , 2019, JAMA neurology.
[13] L. Schwamm,et al. DEFUSE 3 Non-DAWN Patients: A Closer Look at Late Window Thrombectomy Selection , 2019, Stroke.
[14] Hester F. Lingsma,et al. Mediation of the Relationship Between Endovascular Therapy and Functional Outcome by Follow-up Infarct Volume in Patients With Acute Ischemic Stroke , 2019, JAMA neurology.
[15] D. Haussen,et al. Thrombectomy 24 hours after stroke: beyond DAWN , 2018, Journal of NeuroInterventional Surgery.
[16] B. Molyneaux,et al. Thrombectomy 6-24 hours after stroke in trial ineligible patients , 2018, Journal of NeuroInterventional Surgery.
[17] A. Demchuk,et al. Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging , 2018, The New England journal of medicine.
[18] M. Chen,et al. Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct , 2018, The New England journal of medicine.
[19] Posttreatment Infarct Volumes when Compared with 24-Hour and 90-Day Clinical Outcomes: Insights from the REVASCAT Randomized Controlled Trial , 2018, American Journal of Neuroradiology.
[20] A. Demchuk,et al. Time for a Time Window Extension: Insights from Late Presenters in the ESCAPE Trial , 2018, American Journal of Neuroradiology.
[21] Adnan H Siddiqui,et al. Time to Treatment With Endovascular Thrombectomy and Outcomes From Ischemic Stroke: A Meta-analysis. , 2016, JAMA.
[22] H. Diener,et al. Analysis of Workflow and Time to Treatment and the Effects on Outcome in Endovascular Treatment of Acute Ischemic Stroke: Results from the SWIFT PRIME Randomized Controlled Trial. , 2016, Radiology.
[23] Dar Dowlatshahi,et al. Intra-Arterial Therapy and Post-Treatment Infarct Volumes: Insights From the ESCAPE Randomized Controlled Trial , 2016, Stroke.
[24] Eric E. Smith,et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. , 2015, The New England journal of medicine.
[25] M. Rodger,et al. Diagnostic randomized controlled trials: the final frontier , 2012, Trials.
[26] R. G. Steinhauer,et al. The final frontier. , 2000, JEMS : a journal of emergency medical services.